Expert consensus statement on Danshen Chuanxiongqin Injection in clinical practice.
10.19540/j.cnki.cjcmm.20190509.503
- Author:
Yang GAO
1
;
Gui-Qian WANG
2
;
Jian WANG
3
;
Ming-Xue ZHANG
4
;
Yan-Ming XIE
1
;
Huan LIU
1
;
Jun-Jie JIANG
1
Author Information
1. Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
2. Beijing Hospital of Traditional Chinese Medicine,Capital Medical University Beijing 100010,China.
3. Affiliated Hospital of Changchun University of Chinese Medicine Changchun 130021,China.
4. Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang 110032,China.
- Publication Type:Journal Article
- Keywords:
Danshen Chuanxiongqin Injection;
clinical practice;
expert consensus
- MeSH:
Cerebral Infarction;
drug therapy;
Consensus;
Drugs, Chinese Herbal;
therapeutic use;
Humans;
Injections
- From:
China Journal of Chinese Materia Medica
2019;44(14):2937-2942
- CountryChina
- Language:Chinese
-
Abstract:
Danshen Chuanxiongqin Injection is a commonly used medicine in cerebral infarction and coronary heart disease,which is recommended by many disease guidelines/consensus for cardiovascular and cerebrovascular diseases. However,there are irrational drug using in clinic,which affects the efficacy and brings safety risks. Based on clinical research evidence and expert experience,recommendations/consensus suggestion are determined through the nominal group method. The expert consensus recommends the indications,intervention time for treatment,route of drug administration,usage and dosage,course of treatment and introduces the safety in clinical application,which could provide reference for clinical use of Danshen Chuanxiongqin Injection.
